Doctor profile · Federal record
Dr. Yuriy Gurevich, D.O
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · New York, NY
- NPI 1336319680
- Accepts Medicare
- MIPS 88.3 / 100 · 2023
- 23 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
317 E 17Th St, Fierman Hall, 7Th Floor
New York, NY 100033804
(212) 420-2066
fax (212) 420-2224
Credentials & registration
- NPI registered
- March 2008 — 18 yrs on file
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- New York #246338-1
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1336319680. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
10,727
Distinct HCPCS
10
Medicare allowed
$335,027
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 5,460 | 57 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 460 | 246 | $148 | |
36415 |
Insertion of needle into vein for collection of blood sample | 448 | 269 | $8 | |
84550 |
Uric acid level, blood | 402 | 251 | $4 | |
80053 |
Blood test, comprehensive group of blood chemicals | 398 | 248 | $10 | |
84480 |
Thyroid hormone, t3 measurement, total | 362 | 249 | $14 | |
83036 |
Hemoglobin a1c level | 359 | 229 | $9 | |
84439 |
Thyroxine (thyroid chemical), free | 359 | 247 | $9 | |
84443 |
Blood test, thyroid stimulating hormone (tsh) | 354 | 244 | $16 | |
82306 |
Vitamin d-3 level | 348 | 234 | $29 |
In context: peer comparison
Among 92 peers in this city , average services per provider: 220. This provider delivers 49× the peer median.Open Payments
Industry payments received
All-time total
$2,703
Transactions
134
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 22 | $380.39 | |
| Amgen Inc. | 17 | $333.82 | |
| Novo Nordisk Inc | 11 | $212.77 | |
| Mannkind Corporation | 27 | $194.94 | |
| PFIZER INC. | 9 | $172.26 | |
| Antares Pharma, Inc. | 10 | $164.97 | |
| Abbott Laboratories | 6 | $133.04 | |
| Alexion Pharmaceuticals, Inc. | 5 | $118.17 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $115.07 | |
| ABBVIE INC. | 5 | $100.65 | |
| Corcept Therapeutics | 4 | $96.22 | |
| SANOFI-AVENTIS U.S. LLC | 3 | $82.06 | |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76.04 | |
| Insulet Corporation | 3 | $67.14 | |
| Radius Health, Inc. | 3 | $61.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,640
Patients
521
Total drug cost
$1,235,139
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 292 | 92 | $6,772 |
| Metformin Hcl | Generic | 198 | 76 | $2,567 |
| Ozempic (Semaglutide) | Brand | 190 | 53 | $375,493 |
| Atorvastatin Calcium | Generic | 172 | 56 | $2,474 |
| Trulicity (Dulaglutide) | Brand | 145 | 33 | $293,949 |
| Novolog Flexpen (Insulin Aspart) | Brand | 106 | 29 | $145,016 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 76 | 23 | $104,610 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 76 | 26 | $1,133 |
| Synthroid (Levothyroxine Sodium) | Brand | 69 | 23 | $8,514 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 58 | 17 | $54,339 |
Hospital affiliations
Frequently asked questions
What is Dr. Yuriy Gurevich's medical specialty?
Dr. Yuriy Gurevich practices Endocrinology, Diabetes & Metabolism Physician in New York, NY.
Where does Dr. Yuriy Gurevich practice?
Dr. Yuriy Gurevich practices at 317 E 17Th St, New York, NY 100033804. Office phone: 2124202066.
What is Dr. Yuriy Gurevich's NPI?
Dr. Yuriy Gurevich's National Provider Identifier (NPI) is 1336319680, issued by NPPES.
Does Dr. Yuriy Gurevich accept Medicare assignment?
Yes. Dr. Yuriy Gurevich accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Yuriy Gurevich commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Insertion of needle into vein for collection of blood sample (HCPCS 36415). Source: CMS Medicare Physician & Other Practitioners file.